Key facts
- This page summarizes Serge Saxonov's Form 4 filing for 10x Genomics, Inc. (TXG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Sep 2026, 17:19.
Serge Saxonov - 01 Sep 2026 Form 4 Insider Report for 10x Genomics, Inc. (TXG)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- TXG
- Reported as of
- 01 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Sep 2026, 17:19:42 UTC
- Prior SEC filing
- 28 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Randy Wu, as Attorney-in-Fact for Serge Saxonov
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Serge Saxonov filed Form 4 for 10x Genomics, Inc. (TXG) on 03 Sep 2026.
Change
- Previous filing in this sequence was filed on 28 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001786720
Primary reporting owner
Saxonov Serge
- Relationship
- Chief Executive Officer, Director
- Address
- 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON
- Signature
- /s/ Randy Wu, as Attorney-in-Fact for Serge Saxonov
- Signature date
- 03 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TXG
transaction
Class A Common Stock
Gift
- Transaction value
- Shares
- -100
- Change %
- -0.01%
- Price
- $0.000000*
- Shares after
- 1,075,249
- Date
- 01 Sep 2026
- Ownership
- Direct
TXG
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 27
- Date
- 01 Sep 2026
- Ownership
- See footnote
- Footnotes
- F1
TXG
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 213,250
- Date
- 01 Sep 2026
- Ownership
- See footnote
- Footnotes
- F2
TXG
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 71,644
- Date
- 01 Sep 2026
- Ownership
- See footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
Footnote F2
The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
Footnote F3
The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.